1 |
Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis[J]. N Engl J Med, 2018, 378 (19): 1811-1823.
|
2 |
Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis [J]. Lancet, 2017, 389 (10082): 1941-1952.
|
3 |
Xiang FL, Fang M, Yutzey KE. Loss of β-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice[J]. Nat Commun, 2017, 8 (1): 712.
|
4 |
van der Velden JL, Guala AS, Leggett SE, et al. Induction of a mesenchymal expression program in lung epithelial cells by wingless protein (Wnt)/β-catenin requires the presence of c-Jun N-terminal kinase-1 (JNK1)[J]. Am J Respir Cell Mol Biol, 2012, 47 (3): 306-314.
|
5 |
冯晓剑,杨莹,王利华,等. Wnt信号调控骨髓源巨噬细胞参与肾脏纤维化的作用及机制[J/CD].中华肾病研究电子杂志,2018,7(3):126-130.
|
6 |
Dinda B, Dinda S, DasSharma S, et al. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders[J]. Eur J Med Chem, 2017 (131): 68-80.
|
7 |
孟洪宇,常虹.黄芩水煎液及黄芩苷抗大鼠肝纤维化药效作用比较研究[J].世界中医药,2018,13(3):699-702.
|
8 |
王清华,姚旭,魏新智,等.黄芩苷对肺纤维化大鼠肺组织氧化应激的反应及炎症细胞的影响[J].中华中医药学刊,2017,35(6):39-41.
|
9 |
Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse[J]. Am Rev Respir Dis, 1979, 120 (4): 893-899.
|
10 |
Evans CM, Fingerlin TE, Schwarz MI, et al. Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways[J]. Physiol Rev, 2016, 96 (4): 1567-1591.
|
11 |
Nanthakumar CB, Hatley RJ, Lemma S, et al. Dissecting fibrosis: therapeutic insights from the small-molecule toolbox[J]. Nat Rev Drug Discov, 2015, 14(10): 693-720.
|
12 |
Liang W, Huang X, Chen W. The effects of baicalin and baicalein on cerebral ischemia: a review[J]. Aging Dis, 2017, 8 (6): 850-867.
|
13 |
Liu T, Dai W, Li C, et al. Baicalin alleviates silica-induced lung inflammation and fibrosis by inhibiting the Th17 response in C57BL/6 mice[J]. J Nat Prod, 2015, 78 (12): 3049-3057.
|
14 |
Yang MD, Chiang YM, Higashiyama R, et al. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect[J]. Hepatology, 2012, 55 (4): 1271-1281.
|
15 |
Janda CY, Dang LT, You C, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling[J]. Nature, 2017, 545 (7653): 234-237.
|
16 |
Lv X, Li J, Hu Y, et al. Overexpression of miR-27b-3p targeting Wnt3a regulates the signaling pathway of Wnt/β-catenin and attenuates atrial fibrosis in rats with atrial fibrillation[J]. Oxid Med Cell Longev, 2019: 5703764.
|
17 |
Liu X, Zhang Z, Pan S, et al. Interaction between the Wnt/β-catenin signaling pathway and the EMMPRIN/MMP-2, 9 route in periodontitis[J]. J Periodontal Res, 2018, 53 (5): 842-852.
|
18 |
Okazaki H, Sato S, Koyama K, et al. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice[J]. Exp Lung Res, 2019, 45 (7): 188-199.
|
19 |
Guo Y, Mishra A, Howland E, et al. Platelet-derived Wnt antagonist Dickkopf-1 is implicated in ICAM-1/VCAM-1-mediated neutrophilic acute lung inflammation[J]. Blood, 2015, 126 (19): 2220-2229.
|
20 |
Zou W, Zou Y, Zhao Z, et al. Nicotine-induced epithelial-mesenchymal transition via Wnt/β-catenin signaling in human airway epithelial cells[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 304 (4): L199-L209.
|
21 |
Chen W, You J, Zheng Q, et al. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways[J]. Cancer Manag Res, 2018 (10): 1817-1826.
|